Cargando…

The benefits of smoking cessation on survival in cancer patients by integrative analysis of multi‐omics data

Few studies have examined the association between smoking status (including former smokers) at diagnosis and overall survival among cancer patients. We aimed to assess the benefits of quitting smoking on cancer prognosis in cohorts of cancer patient smokers obtained from the Cancer Genome Atlas (TCG...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Sheng, Liu, Tong, Liang, Geyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463331/
https://www.ncbi.nlm.nih.gov/pubmed/32580248
http://dx.doi.org/10.1002/1878-0261.12755
_version_ 1783577107140444160
author Yang, Sheng
Liu, Tong
Liang, Geyu
author_facet Yang, Sheng
Liu, Tong
Liang, Geyu
author_sort Yang, Sheng
collection PubMed
description Few studies have examined the association between smoking status (including former smokers) at diagnosis and overall survival among cancer patients. We aimed to assess the benefits of quitting smoking on cancer prognosis in cohorts of cancer patient smokers obtained from the Cancer Genome Atlas (TCGA) database. Hazard ratios (HR) were calculated to evaluate smoking behavior at cancer diagnosis (reformed smokers vs. current smokers) in association with overall survival using multivariate‐adjusted Cox regressions analysis. According to our analyses, quitting smoking was the independent protective factor for overall survival in lung squamous cell carcinoma (LUSC) (HR = 0.67, 95% CI = 0.48–0.94). Comprehensive analysis of multicomponent data across reformed and current smokers identified a total of 85 differential expressed genes (DEGs) affected by different modes of genetic and epigenetic regulation, potentially representing cancer drivers in smokers. Moreover, we provided a smoking‐associated gene expression signature, which could evaluate the true effect on prognosis with high power (HR = 1.70, 95% CI = 1.19–2.43, AUC = 0.65, 0.67, and 0.70 for 2‐, 3‐, and 5‐year survival, respectively). This signature was also applicable in other smoking‐related cancers, including bladder urothelial carcinoma (HR = 1.70, 95% CI = 1.01–2.88), cervical carcinoma (HR = 5.69, 95% CI = 1.37–23.69), head and neck squamous cell carcinoma (HR = 1.97, 95% CI = 1.41–2.76), lung adenocarcinoma (HR = 1.73, 95% CI = 1.16–2.57), and pancreatic adenocarcinoma (HR = 4.28, 95% CI = 1.47–12.47). In conclusion, this study demonstrates that quitting smoking at diagnosis decreases risk of death in cancer patients. We also provide a smoking‐associated gene expression signature to evaluate the effect of smoking on survival. Lastly, we suggest that smoking cessation could comprise a part of cancer treatment to improve survival rates of cancer patients.
format Online
Article
Text
id pubmed-7463331
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-74633312020-09-08 The benefits of smoking cessation on survival in cancer patients by integrative analysis of multi‐omics data Yang, Sheng Liu, Tong Liang, Geyu Mol Oncol Research Articles Few studies have examined the association between smoking status (including former smokers) at diagnosis and overall survival among cancer patients. We aimed to assess the benefits of quitting smoking on cancer prognosis in cohorts of cancer patient smokers obtained from the Cancer Genome Atlas (TCGA) database. Hazard ratios (HR) were calculated to evaluate smoking behavior at cancer diagnosis (reformed smokers vs. current smokers) in association with overall survival using multivariate‐adjusted Cox regressions analysis. According to our analyses, quitting smoking was the independent protective factor for overall survival in lung squamous cell carcinoma (LUSC) (HR = 0.67, 95% CI = 0.48–0.94). Comprehensive analysis of multicomponent data across reformed and current smokers identified a total of 85 differential expressed genes (DEGs) affected by different modes of genetic and epigenetic regulation, potentially representing cancer drivers in smokers. Moreover, we provided a smoking‐associated gene expression signature, which could evaluate the true effect on prognosis with high power (HR = 1.70, 95% CI = 1.19–2.43, AUC = 0.65, 0.67, and 0.70 for 2‐, 3‐, and 5‐year survival, respectively). This signature was also applicable in other smoking‐related cancers, including bladder urothelial carcinoma (HR = 1.70, 95% CI = 1.01–2.88), cervical carcinoma (HR = 5.69, 95% CI = 1.37–23.69), head and neck squamous cell carcinoma (HR = 1.97, 95% CI = 1.41–2.76), lung adenocarcinoma (HR = 1.73, 95% CI = 1.16–2.57), and pancreatic adenocarcinoma (HR = 4.28, 95% CI = 1.47–12.47). In conclusion, this study demonstrates that quitting smoking at diagnosis decreases risk of death in cancer patients. We also provide a smoking‐associated gene expression signature to evaluate the effect of smoking on survival. Lastly, we suggest that smoking cessation could comprise a part of cancer treatment to improve survival rates of cancer patients. John Wiley and Sons Inc. 2020-07-11 2020-09 /pmc/articles/PMC7463331/ /pubmed/32580248 http://dx.doi.org/10.1002/1878-0261.12755 Text en © 2020 The Authors. Published by FEBS Press and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Yang, Sheng
Liu, Tong
Liang, Geyu
The benefits of smoking cessation on survival in cancer patients by integrative analysis of multi‐omics data
title The benefits of smoking cessation on survival in cancer patients by integrative analysis of multi‐omics data
title_full The benefits of smoking cessation on survival in cancer patients by integrative analysis of multi‐omics data
title_fullStr The benefits of smoking cessation on survival in cancer patients by integrative analysis of multi‐omics data
title_full_unstemmed The benefits of smoking cessation on survival in cancer patients by integrative analysis of multi‐omics data
title_short The benefits of smoking cessation on survival in cancer patients by integrative analysis of multi‐omics data
title_sort benefits of smoking cessation on survival in cancer patients by integrative analysis of multi‐omics data
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463331/
https://www.ncbi.nlm.nih.gov/pubmed/32580248
http://dx.doi.org/10.1002/1878-0261.12755
work_keys_str_mv AT yangsheng thebenefitsofsmokingcessationonsurvivalincancerpatientsbyintegrativeanalysisofmultiomicsdata
AT liutong thebenefitsofsmokingcessationonsurvivalincancerpatientsbyintegrativeanalysisofmultiomicsdata
AT lianggeyu thebenefitsofsmokingcessationonsurvivalincancerpatientsbyintegrativeanalysisofmultiomicsdata
AT yangsheng benefitsofsmokingcessationonsurvivalincancerpatientsbyintegrativeanalysisofmultiomicsdata
AT liutong benefitsofsmokingcessationonsurvivalincancerpatientsbyintegrativeanalysisofmultiomicsdata
AT lianggeyu benefitsofsmokingcessationonsurvivalincancerpatientsbyintegrativeanalysisofmultiomicsdata